Oxymatrine therapy for chronic hepatitis B: A randomized double-blind and placebo-controlled multi-center trial

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

526

HTML

3108

Tables (1-3)

138

Sum=3772

Nov 15, 2003 (publication date) through Jul 16, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Nov 15, 2003; 9(11): 2480-2483
Published online Nov 15, 2003. doi: 10.3748/wjg.v9.i11.2480

Table 2 Normalization rate of serum ALT and comparison among capsule oxymatrine group, injection oxymatrine group and placebo group

Group	Number of ALT abnormality before treatment	Number of ALT normalization after treatment	Normalizationrate (%)	Comparison among 3 groups
Group	Number of ALT abnormality before treatment	Number of ALT normalization after treatment	Normalizationrate (%)	χ²	P value
Capsule	102	78	76.47
Injection	30	25	83.33	28.352	0.001
Placebo	65	26	40.00

The comparison of ALT normalization rate was performed with χ² test, statistic was χ².

Citation: Lu LG, Zeng MD, Mao YM, Li JQ, Wan MB, Li CZ, Chen CW, Fu QC, Wang JY, She WM, Cai X, Ye J, Zhou XQ, Wang H, Wu SM, Tang MF, Zhu JS, Chen WX, Zhang HQ. Oxymatrine therapy for chronic hepatitis B: A randomized double-blind and placebo-controlled multi-center trial. World J Gastroenterol 2003; 9(11): 2480-2483
URL: https://www.wjgnet.com/1007-9327/full/v9/i11/2480.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i11.2480